News
March 10, 2025
(opens in a new tab)OnKure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
March 4, 2025
(opens in a new tab)OnKure Therapeutics to Present at Upcoming Leerink and Stifel Investor Conferences
December 10, 2024
(opens in a new tab)OnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic (PK) Data from its First-In-Human PIKture-01 Trial of OKI-219
- View All News(opens in a new tab)